Curing Our COVID Myopia (w/Dr. Marty Makary)
What this video covers
In this May 2022 return to the ZDoggMD Show, Dr. Marty Makary and host Zubin Damania step back from the daily COVID numbers to ask a bigger question: what has the single-minded focus on COVID cost everything else? The show’s framing — “What has our narrow vision cost us?” — sets up a discussion of the collateral damage Makary argues accumulated while public-health institutions aimed every resource at the pandemic.
The conversation reflects Makary’s core complaint of the period: that delayed cancer screenings, deferred elective care, shuttered schools, and untreated chronic conditions were the neglected half of the pandemic ledger. His signature anecdote: a charity network of summer camps for children with a disability that didn’t raise COVID risk reopened without bus service, so only parents who could afford to drive could send their kids — the kind of collateral damage he says the narrow COVID lens missed. He argues the infection fatality rate was by then about 20 times lower in people with immunity, that roughly 95% of adults over 12 had immunity from vaccination or infection (citing CDC data), and that Omicron “probably should have a different name” so as not to conjure the earlier virus’s image. He also accuses the CDC of selectively withholding data — suicide figures since January 2021 and booster-hospitalization rates for under-50s — and of still not collecting the pandemic’s most important metric, hospitalizations for COVID rather than with it.
Recorded as the country was formally moving into the endemic phase, the episode captures Makary’s pivot from pandemic commentator to healthcare-system reformer — the posture he carried into his FDA commissioner nomination three years later.
Key points
- The episode’s premise is that the pandemic response’s narrow COVID focus damaged or neglected other areas of health and society — the “myopia” of the title.
- Makary argues, per the show’s framing, that public-health institutions need to account for the full ledger of costs, not just COVID metrics.
- The conversation ties into Makary’s “Redesigning Healthcare” movement at Johns Hopkins, his pre-FDA reform project.
- Aired May 2022, it marks Makary’s transition from pandemic-era pundit to system-reform advocate — the trajectory that later made him a MAHA-aligned FDA pick.
- Like his other ZDoggMD appearances, the tone is dissenting-insider rather than partisan: two physicians critiquing the establishment from within medicine.